References 
1. Rosenberg, S.A.: Adoptive Immunotherapy of Cancer Using Lymphokine 
Activated Killer Cells and Recombinant Interleukin-2. In: DeVita, VT, 
Heilman, S, Rosenberg, SA (eds.). Important Advances in Oncology, 1986, 
Philadelphia, J.B. Lippincott, 1986; 55-911. 
2. Rosenberg, S.A.: The development of new immunotherapies for the 
treatment of cancer using interleukin-2. Ann. Sure. 208:121-135, 1988. 
3. Rosenberg, S.A., Lotze, M.T., Yang,, J.C., Aebersold, P.M., Linehan, 
W.M. , Seipp, C. A. and White, D.E.: Experience with the use of high-dose 
interleukin-2 in the treatment of 652 cancer patients. Ann. Surq. 
210:474-485, 1989. 
4. Rosenberg, S.A., Lotze, M.T., Muul, L.M. , Chang, A.E., Avis, F.P., 
Leitman, S., Linehan, W.M. , Robertson, C.N., Lee, R.E., Rubin, J.T., 
Seipp, C.A., Simpson, C.G., and White, D.E.: A progress report on the 
treatment of 157 patients with advanced cancer using lymphokine-activated 
killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl 
J Med 316:889-897, 1987. 
5. Rosenberg, S.A., Packard, B.S., Aebersold, P.M., Solomon, D., Topalian, 
S.L., Toy, S.T., Simon, P., Lotze, M.T., Yang, J.C., Seipp, C.A., 
Simpson, C. , Carter, C. , Bock, S., Schwartzentruber , D., Wei, J.P., and 
White, D.E.: Use of tumor-infiltrating lymphocytes and interleukin-2 in 
the immunotherapy of patients with metastatic melanoma. A preliminary 
report. N Engl J Med 319:1676-1680, 1988. 
[94] 
Recombinant DNA Research, Volume 15 
